← FDA Drug Approvals (Drugs@FDA)

QINLOCK

NDA · New Drug Application · Sponsor: DECIPHERA PHARMS · Approved 2020-05-15

Drug application

FDA Application #

NDA213973

Application type

New Drug Application

Brand name

QINLOCK

Generic name

RIPRETINIB

Active ingredients

RIPRETINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

DECIPHERA PHARMS

Manufacturer

Deciphera Pharmaceuticals, LLC

First approval

2020-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown